These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity. Liu Y; Huang H; Chen Z; Zong L; Xiang J J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636 [TBL] [Abstract][Full Text] [Related]
4. Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus. Diaconu I; Cerullo V; Hirvinen ML; Escutenaire S; Ugolini M; Pesonen SK; Bramante S; Parviainen S; Kanerva A; Loskog AS; Eliopoulos AG; Pesonen S; Hemminki A Cancer Res; 2012 May; 72(9):2327-38. PubMed ID: 22396493 [TBL] [Abstract][Full Text] [Related]
5. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect. Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479 [TBL] [Abstract][Full Text] [Related]
6. Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy. Bernt KM; Ni S; Tieu AT; Lieber A Cancer Res; 2005 May; 65(10):4343-52. PubMed ID: 15899826 [TBL] [Abstract][Full Text] [Related]
7. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus. Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462 [TBL] [Abstract][Full Text] [Related]
9. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus. Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667 [TBL] [Abstract][Full Text] [Related]
10. No defect in T-cell priming, secondary response, or tolerance induction in response to inhaled antigens in Fms-like tyrosine kinase 3 ligand-deficient mice. Walzer T; Brawand P; Swart D; Tocker J; De Smedt T J Allergy Clin Immunol; 2005 Jan; 115(1):192-9. PubMed ID: 15637568 [TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model. Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994 [TBL] [Abstract][Full Text] [Related]
13. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo. Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026 [TBL] [Abstract][Full Text] [Related]
14. Intravenous administration of MIP-1alpha with intra-tumor injection of P. acnes shows potent anti-tumor effect. Nakano A; Yoneyama H; Ueha S; Kitabatake M; Ishikawa S; Kawase I; Sugiyama H; Matsushima K Int Immunopharmacol; 2007 Jun; 7(6):845-57. PubMed ID: 17466918 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of MIP-1alpha-recruited dendritic cells on preestablished solid and metastatic tumors. Cao Q; Jin Y; Jin M; He S; Gu Q; He S; Qiu Y; Ge H; Yoneyama H; Zhang Y Cancer Lett; 2010 Sep; 295(1):17-26. PubMed ID: 20202744 [TBL] [Abstract][Full Text] [Related]
16. Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice. Su C; Peng L; Sham J; Wang X; Zhang Q; Chua D; Liu C; Cui Z; Xue H; Wu H; Yang Q; Zhang B; Liu X; Wu M; Qian Q Mol Ther; 2006 May; 13(5):918-27. PubMed ID: 16497559 [TBL] [Abstract][Full Text] [Related]
17. A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent. Zou W; Luo C; Zhang Z; Liu J; Gu J; Pei Z; Qian C; Liu X Oncogene; 2004 Jan; 23(2):457-64. PubMed ID: 14724574 [TBL] [Abstract][Full Text] [Related]
18. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus. Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206 [TBL] [Abstract][Full Text] [Related]
19. Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection. Solheim JC; Reber AJ; Ashour AE; Robinson S; Futakuchi M; Kurz SG; Hood K; Fields RR; Shafer LR; Cornell D; Sutjipto S; Zurawski S; LaFace DM; Singh RK; Talmadge JE Cancer Gene Ther; 2007 Apr; 14(4):364-71. PubMed ID: 17235356 [TBL] [Abstract][Full Text] [Related]
20. A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy. Watanabe Y; Kojima T; Kagawa S; Uno F; Hashimoto Y; Kyo S; Mizuguchi H; Tanaka N; Kawamura H; Ichimaru D; Urata Y; Fujiwara T Oncogene; 2010 Feb; 29(8):1145-54. PubMed ID: 19935710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]